Pfizer To Buy Trillium Therapeutics For $18.50/Shr Cash - Quick Facts
23/8 13:18
(RTTNews) - Pfizer Inc. (PFE) and Trillium Therapeutics Inc. (TRIL) announced Monday that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium, a clinical stage immuno-oncology company developing innovative therapies for the treatment of...